Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond (CROSBI ID 313375)
Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija
Podaci o odgovornosti
Repac Antić, Davorka ; Parčina, Marijo ; Gobin, Ivana ; Petković Didović, Mirna
engleski
Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond
In the era of escalating antimicrobial resistance, the need for antibacterial drugs with novel or improved modes of action (MOAs) is a health concern of utmost importance. Adding or improving the chelating abilities of existing drugs or finding new, nature-inspired chelating agents seems to be one of the major ways to ensure progress. This review article provides insight into the modes of action of antibacterial agents, class by class, through the perspective of chelation. We covered a wide scope of antibacterials, from a century-old quintessential chelating agent nitroxoline, currently unearthed due to its newly discovered anticancer and antibiofilm activities, over the commonly used antibacterial classes, to new cephalosporin cefiderocol and a potential future class of tetramates. We show the impressive spectrum of roles that chelation plays in antibacterial MOAs. This, by itself, demonstrates the importance of understanding the fundamental chemistry behind such complex processes.
chelation ; antibacterial drugs ; nitroxoline ; antibacterial modes of action (MOAs)
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Farmacija, Kemija, Temeljne medicinske znanosti